Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic acid to upregulate SSTR2 in SSTR2-low or SSTR2-negative neuroendocrine tumors
NL-OMON55794Recruiting
- Sponsor
- Erasmus MC
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of valproic acid in apudoma (NET) and Carcinoid Tumor (CT), sponsored by Erasmus MC. Primary endpoint: Increase in 68Ga-DOTATATE uptake on Krenning scale. Started Jul 2019; status: recruiting.
02
Drugs
valproic acid
03
Conditions
apudoma (NET)Carcinoid Tumor (CT)
Beyond the preview
Go deeper on NL-OMON55794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55794.